Cosmo Pharmaceuticals N.V. (SWX:COPN)
86.90
+0.50 (0.58%)
Apr 2, 2026, 5:30 PM CET
Cosmo Pharmaceuticals Employees
Cosmo Pharmaceuticals had 325 employees as of December 31, 2025. The number of employees increased by 3 or 0.84% compared to the previous year.
Employees
325
Change (1Y)
3
Growth (1Y)
0.84%
Revenue / Employee
298.42K CHF
Profits / Employee
-10.34K CHF
Market Cap
1.40B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 325 | 3 | 0.84% |
| Dec 31, 2024 | 322 | -3 | -0.98% |
| Dec 31, 2023 | 325 | 30 | 10.17% |
| Dec 31, 2022 | 295 | 5 | 1.72% |
| Dec 31, 2021 | 290 | 25 | 9.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,267 |
| Lonza Group AG | 19,771 |
| Galderma Group AG | 7,676 |
| Aevis Victoria | 4,731 |
| Tecan Group AG | 3,305 |
| SKAN Group AG | 1,504 |
| PolyPeptide Group AG | 1,440 |
Cosmo Pharmaceuticals News
- 21 days ago - Cosmo Pharmaceuticals NV (CMOPF) Full Year 2025 Earnings Call Highlights: Strong Financial ... - GuruFocus
- 21 days ago - Full Year 2025 Cosmo Pharmaceuticals NV Earnings Call Transcript - GuruFocus
- 24 days ago - Cosmo Pharmaceuticals (CMOPF) Reports Revenue Decline, Sets Positive 2026 Outlook - GuruFocus
- 24 days ago - Cosmo Pharma Slips To Loss In FY25 On Weak Revenues; Stock Drops - Nasdaq